Cyclooxygenase 2Cyclooxygenase 1Cyclooxygenase InhibitorsCyclooxygenase 2 InhibitorsProstaglandin-Endoperoxide SynthasesDinoprostoneIndomethacinProstaglandinsIsoenzymesArachidonic AcidNitrobenzenesAnti-Inflammatory Agents, Non-SteroidalSulfonamidesLipoxygenase InhibitorsPyrazolesIbuprofenThromboxane B2Membrane ProteinsArachidonic AcidsProportional Hazards Models6-Ketoprostaglandin F1 alphaEicosanoidsFlurbiprofenLipoxygenaseAspirinEpoprostenolMasoprocolPiroxicamDiclofenacIntramolecular OxidoreductasesReceptors, Prostaglandin EThromboxane A2Electron Transport Complex IVNaproxenArachidonate 5-LipoxygenaseThromboxane-A SynthaseThiazinesHydroxyeicosatetraenoic AcidsThromboxanesMeclofenamic AcidDinoprostProstaglandins GSeminal VesiclesSulfones5,8,11,14-Eicosatetraynoic AcidGene Expression Regulation, EnzymologicLactonesDose-Response Relationship, DrugNitric Oxide4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineRNA, MessengerVasodilationNitric Oxide SynthaseProstaglandins EPhospholipases AEnzyme InductionCells, CulturedPrognosisSulindacPhospholipases A2KetorolacEnzyme InhibitorsTime FactorsProstaglandin H2LeukotrienesRats, Sprague-DawleyReceptors, Prostaglandin E, EP4 Subtype8,11,14-Eicosatrienoic AcidEndothelium, VascularRisk FactorsVasoconstrictionProstaglandin D2Receptors, Prostaglandin E, EP1 SubtypeReceptors, ThromboxaneArachidonate LipoxygenasesBradykininCohort StudiesLeukotriene B4Receptors, Prostaglandin E, EP2 SubtypeCalcimycinBlotting, WesternSurvival AnalysisProstaglandin AntagonistsTolmetinHydrazinesFollow-Up StudiesRats, WistarNitric Oxide Synthase Type IIImmunohistochemistryLipopolysaccharidesSalicylatesInterleukin-1Prostaglandins HNG-Nitroarginine Methyl EsterBlood PlateletsSheepProspective StudiesKaplan-Meier EstimateReceptors, ProstaglandinPeroxidases